We believe that everyone deserves a good life, and for some that is only possible when the medicine is just right. Therefore we are writing a new chapter in personalized medicine. OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. OnDosis is currently developing products for individualized dosing to help 100's of thousands of patients diseases with a significant unmet needs such as ADHD, food allergies, pain and immunosuppression for organ transplants. OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered at GoCo House in Gothenburg, Sweden.
Extern länk för OnDosis
Gemenskapens gata 9
GoCo House
Gothenburg, Västra Götaland County 431 53, SE
OnDosis omdelade detta
Team Pharma Partnering Summit would like to take this opportunity to express special gratitude to Shane Maloney of Servier, Dr Natalie L. Curtis of DyoDelta Biosciences Ltd., Igor Orshanskiy of InflaRx N.V., Jonas Bäck of OnDosis and Eden Ben of AMORPHICAL for sharing their knowledge, experience and unique perspective during a panel discussion at Pharma Partnering EU Summit 2024 in Basel.
Great feature of OnDosis in EU Startup News
💊🧪 Are we standing on the brink of a revolution in the field of personalised medication dosing? One amazing startup, OnDosis, certainly believes so. Based in Sweden, OnDosis is developing groundbreaking technology for flexible and individualized dosing of oral medications. Imagine a world where prescribed medicines are in micro units, ensuring the right dose for every unique patient. This innovation has the potential to significantly improve disease management, promote patient adherence, and provide a level of convenience that's unprecedented in healthcare. OnDosis was brought to life by the visionary Martin Olovsson, and their groundbreaking work is aimed at transforming the lives of hundreds of thousands of patients struggling with conditions such as ADHD, pain management and each post-organ transplant. Discover more about how @OnDosis is changing the face of pharmaceuticals in our latest article ⬇️ https://lnkd.in/eKK2B9GX Join the conversation and weigh in on the future of medicine! 🚀🌐 #PharmaceuticalInnovation #HealthTech #EUStartups #IndividualisedDosing #FutureHealthcare Startup featured: OnDosis [LinkedIn](https://lnkd.in/e-ZYBy-G) Founder: Martin Olovsson Location: Mölndal, Vastra Gotaland, Sweden
We're exhibiting and speaking at Pharmapack Europe in Paris 24-25th January. Come visit us in the Start-Up Hub 💡 and learn more about how we address individualized dosing of oral solids! #precisionmedicine #innovation #medtech #individualization #digitalhealth #flexibledosing
Camallergy and OnDosis announce a groundbreaking partnership to revolutionize food allergy treatment https://lnkd.in/dK8m7Pgx
We're excited to be an exhibitor at #PODD2023 in Boston Oct 16-17th! Learn more about OnDosis and how individualization is made simple at https://www.ondosis.com http://poddconference.com/ PODD: Partnership Opportunities in Drug Delivery Community News #PODD2023 #precisionmedicine #innovation #medtech #individualization #digitalhealth #flexibledosing
Senaste finansieringsrunda
Okänd serie11 057 314,00 US$